Studies of linear ubiquitin and different modes of cell death induction by TNFfamily members in aetiology and treatment of auto-immunity (360G-Wellcome-096831_Z_11_A)
I. What are the inducers, mechanisms and immunological consequences of proinflammatorycell death when ubiquitin-signalling is perturbed and how can they beinhibited?II. Can type-II auto-immunity be treated by preventing pro-inflammatory cell death and/orits immunological consequences?III. Can we identify auto-immune patients who may benefit from a therapy that preventsnecroptosis and/or its pro-inflammatory consequences?
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 2654537 |
Applicant Surname | Walczak |
Approval Committee | Science Interview Panel |
Award Date | 2011-10-04T00:00:00+00:00 |
Financial Year | 2011/12 |
Grant Programme: Title | Investigator Award in Science |
Internal ID | 096831/Z/11/A |
Lead Applicant | Prof Henning Walczak |
Partnership Value | 2654537 |
Planned Dates: End Date | 2018-12-31T00:00:00+00:00 |
Planned Dates: Start Date | 2013-01-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | Greater London |